Dr. Goldfinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
506 6th St
Brooklyn, NY 11215Phone+1 646-221-7710
Education & Training
- Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2014 - 2017
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2011 - 2014
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2011
Certifications & Licensure
- NY State Medical License 2017 - 2026
- NJ State Medical License 2015 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort.Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, Yogen Saunthararajah, Kira Gritsman
Blood. 2024-11-28 - Inter-racial genetic differences in myelofibrosis: a diverse inner-city center analysis.Josette Kamel, John Yan, Bradley Rockwell, Mendel Goldfinger, Eric J Feldman
Leukemia & Lymphoma. 2024-10-21 - 1 citationsExploring health disparities in diagnosing multiple myeloma.Nima Ghalehsari, Sofia Zahid, Olivia Main, Soeb Usta, John Patresan
Expert Review of Hematology. 2024-10-01
Press Mentions
- 14 Cancer Warning Signs Your Doctor Should Never IgnoreJuly 11th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: